| Literature DB >> 25556809 |
Paul P Lerner1, Chanoch Miodownik2, Vladimir Lerner2.
Abstract
Tardive dyskinesia is a serious, disabling and potentially permanent, neurological hyperkinetic movement disorder that occurs after months or years of taking psychotropic drugs. The pathophysiology of tardive dyskinesia is complex, multifactorial and still not fully understood. A number of drugs were tried for the management of this motor disturbance, yet until now no effective and standard treatment has been found. It is very disappointing to realize that the introduction of antipsychotics from the second generation has not significantly decreased the prevalence and incidence of tardive dyskinesia. Therefore, the management of this motor disturbance remains an actual topic as well as a challenge for clinicians. This review summarizes recent relevant publications concerning the treatment of tardive dyskinesia.Entities:
Keywords: first-generation agents; management; schizophrenia; second-generation agents; tardive dyskinesia
Mesh:
Substances:
Year: 2015 PMID: 25556809 DOI: 10.1111/pcn.12270
Source DB: PubMed Journal: Psychiatry Clin Neurosci ISSN: 1323-1316 Impact factor: 5.188